𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative SPECT/CT reconstruction for 177 Lu and 177 Lu/ 90 Y targeted radionuclide therapies

✍ Scribed by Shcherbinin, S; Piwowarska-Bilska, H; Celler, A; Birkenfeld, B

Book ID
120090291
Publisher
Institute of Physics
Year
2012
Tongue
English
Weight
834 KB
Volume
57
Category
Article
ISSN
0031-9155

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical results of radionuclide therapy
Clinical results of radionuclide therapy of neuroendocrine tumours with90Y-DOTATATE and tandem90Y/177Lu-DOTATATE: which is a better therapy option?
✍ Jolanta Kunikowska; Leszek KrΓ³licki; Alicja Hubalewska-Dydejczyk; Renata MikoΕ‚aj πŸ“‚ Article πŸ“… 2011 πŸ› Springer 🌐 English βš– 487 KB

## Purpose Peptide receptor radionuclide therapy (PRRT) using radiolabelled somatostatin analogues is a treatment option for patients with disseminated neuroendocrine tumours (NET). A combination treatment using the high-energy ^90^Y beta emitter for larger lesions and the lower energy ^177^Lu for